T&L

340570KOSDAQHealth CareTrading normally
US$19.32
▼ −US$0.26 (−1.35%)Close · 2026-10-21
Share price
▲ +9.0%over 1y
25/1026/0126/0426/0726/10
$20$25

Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.

What the company does

T&L makes wound dressings, medical coverings that protect injuries, absorb fluid, and prevent contamination, along with microneedles and orthopaedic immobilisation supports such as casts and splints.

Its products are used in medical and personal-care settings, and the company is listed on KOSDAQ, South Korea's tech and small-cap exchange. Wound dressings form the core of its business, with microneedle and cosmetic products developed as extensions of the same advanced polymer materials technology.

Summary is AI-generated and may contain errors · figures from DART filings

KEY FACTS
Market capUS$310.5M
SectorHealth Care
SubsectorPharmaceuticals
MarketKOSDAQ
Cap tierSmall-cap
Financials
6Y · FY2020~2025 · USD · all filed years
Revenue
US$123.9MFY2025 · latest
'20'22'25
low US$30.7Mhigh US$132M
Operating profit
US$35MFY2025 · latest
'20'22'25
low US$7.2Mhigh US$43M
Net income
US$28.7MFY2025 · latest
'20'22'25
low US$7.6Mhigh US$35M
Hover or tap a year for its figure · red dot = loss year · latest FY2025
Quick answers

T&L in five facts

What does T&L do?

T&L makes wound dressings, medical coverings that protect injuries, absorb fluid, and prevent contamination, along with microneedles and orthopaedic immobilisation supports such as casts and splints.

Where is T&L listed and in which sector?

T&L (Korean name: 티앤엘) trades under KRX code 340570 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Pharmaceuticals.

How large is T&L?

Its market capitalisation was US$310.5M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).

What were T&L's latest annual revenue and operating profit?

For fiscal year 2025, T&L reported revenue of US$123.9M, operating profit of US$35M and net income of US$28.7M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was down 6.1% on the previous year.

Where does this data come from?

Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.

Data sources

Data sources and last updated

Filings and financial statements
DART (dart.fss.or.kr), Korea's official corporate-filing system
Prices, market cap, trading status
KRX (Korea Exchange), via FinanceDataReader
Latest annual financials
Fiscal year 2025, data retrieved from DART on 2026-10-02
Share price and market cap
Close of 2026-10-21
Currency
US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
Company data updated
2026-10-21
Company summary
AI-generated from filings; may contain errors. Information only, not investment advice.